Neutropenia, Cyclic

Neutropenia, Cyclic is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

Basics

Description

  • A rare hematologic disorder characterized by recurrent fevers, mouth ulcers, and infections attributable to regularly recurring severe neutropenia
  • Although inherited in an autosomal dominant pattern, mutations in the gene for neutrophil elastase (ELA-2), sporadic mutations can occur; characterized by neutropenia that recurs every 14 to 35 days, with 90% of patients exhibiting a cycle of 21 days
  • During the neutropenic period, blood neutrophil levels fall to <0.2 × 109/L for 3 to 5 days, before increasing to near the lower limit of normal, ~2 × 109/L.

Epidemiology

  • Most patients present before the age of 5 years:
    • 32% are <1 year of age.
    • 27% are between ages 1 and 5 years.
  • Occurs equally in both sexes

Incidence
1 to 2 in a million people

Etiology and Pathophysiology

  • Bone marrow during neutropenia demonstrates “maturation arrest” at the promyelocyte and myelocyte stage of development.
  • At least 80% of cases of cyclic neutropenia are attributable to the mutations for neutrophil elastase (ELA-2/ELANE).
  • This mutation results in accelerated apoptosis of neutrophil progenitors, making neutrophil production inefficient.
  • It is not known if any other mutations can cause this disease.
  • The cause of acquired cyclic neutropenia is unknown.

Genetics

  • Autosomal dominant disorder with full penetrance but varying severity of clinical manifestations (expression)
  • Most commonly sporadic
  • Due to mutations in the gene for neutrophil elastase (ELA-2 or ELANE) on chromosome 19p13.3 (1)[A]

Risk Factors

  • Family history is predictive, although patients proven to have the (ELA) mutation will lack positive family history due to subclinical presentation among family members, new mutation, or variability in expression.
  • Neutropenia may also be inherited. This condition is called ethnic benign neutropenia because it is not associated with any type of infection.

General Prevention

Genetic counseling

-- To view the remaining sections of this topic, please or --

Basics

Description

  • A rare hematologic disorder characterized by recurrent fevers, mouth ulcers, and infections attributable to regularly recurring severe neutropenia
  • Although inherited in an autosomal dominant pattern, mutations in the gene for neutrophil elastase (ELA-2), sporadic mutations can occur; characterized by neutropenia that recurs every 14 to 35 days, with 90% of patients exhibiting a cycle of 21 days
  • During the neutropenic period, blood neutrophil levels fall to <0.2 × 109/L for 3 to 5 days, before increasing to near the lower limit of normal, ~2 × 109/L.

Epidemiology

  • Most patients present before the age of 5 years:
    • 32% are <1 year of age.
    • 27% are between ages 1 and 5 years.
  • Occurs equally in both sexes

Incidence
1 to 2 in a million people

Etiology and Pathophysiology

  • Bone marrow during neutropenia demonstrates “maturation arrest” at the promyelocyte and myelocyte stage of development.
  • At least 80% of cases of cyclic neutropenia are attributable to the mutations for neutrophil elastase (ELA-2/ELANE).
  • This mutation results in accelerated apoptosis of neutrophil progenitors, making neutrophil production inefficient.
  • It is not known if any other mutations can cause this disease.
  • The cause of acquired cyclic neutropenia is unknown.

Genetics

  • Autosomal dominant disorder with full penetrance but varying severity of clinical manifestations (expression)
  • Most commonly sporadic
  • Due to mutations in the gene for neutrophil elastase (ELA-2 or ELANE) on chromosome 19p13.3 (1)[A]

Risk Factors

  • Family history is predictive, although patients proven to have the (ELA) mutation will lack positive family history due to subclinical presentation among family members, new mutation, or variability in expression.
  • Neutropenia may also be inherited. This condition is called ethnic benign neutropenia because it is not associated with any type of infection.

General Prevention

Genetic counseling

There's more to see -- the rest of this topic is available only to subscribers.